Sezaby Injection
Product Images NDC 62756-301

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sezaby (NDC 62756-301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sezaby-1 (Sezaby 1)

Chemical structure of phenobarbital sodium is depicted, showing the barbiturate core with a sodium ion and ethyl and phenyl substituents.*

FDA Label Image

Sezaby-002 (Sezaby 002)

Label for SEZABY injection containing phenobarbital sodium 100 mg per vial by Sun Pharmaceutical Industries, Inc. Instructions indicate reconstitution with 10 mL of 0.9% Sodium Chloride Injection to yield 10 mg/mL. The single-dose vial is sterile and lyophilized, intended for slow intravenous use after reconstitution. Manufactured by Gland Pharma Limited, Hyderabad, India.*

FDA Label Image

Sezaby-02 (Sezaby 02)

The packaging label for SEZABY phenobarbital sodium injection, 100 mg per vial, by Sun Pharmaceutical Industries, Inc. The label indicates it is for intravenous use only, single-dose vial, sterile lyophilized form. It includes storage instructions, dosing notes, manufacturer and distributor information, and barcodes. The label emphasizes Rx only status.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.